Pfizer, Biohaven enter $1.24b collaboration deal on migraine drug November 9, 2021 Auto Bot Markets & Regulations 0 Under the terms of the strategic arrangement, Pfizer would handle commercialization for Biohavenâs rimegepant in markets outside the bounds of the US.